| 9.90 Data as of Jun 18 |  +0.03 / +0.30%Today’s Change | 4.02 Today|||52-Week Range 10.40 | +57.14% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $355.4M |
Regulus Therapeutics, Inc. 3545 John Hopkins Centre San Diego California 92121-1121 |
| Mutual fund holders | 4.45% |
| Individual stakeholders | 28.17% |
| Other institutional | 17.93% |
| Kleanthis G. Xanthopoulos, PhD | President, Chief Executive Officer & Director |
| Garry E. Menzel, PhD, MBA | Chief Operating Officer & Executive VP-Finance |
| Neil W. Gibson, PhD | Chief Scientific Officer |
| Mary Glanville, | Senior Vice President-Human Capital |
| Victor Knopov, PhD | Vice President-Pharmaceutical Development |
.
